首页 > 最新文献

Ophthalmology最新文献

英文 中文
Amblyogenic Apex: The Pyramid Within the Eye. 安眠顶点:眼球内的金字塔
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-14 DOI: 10.1016/j.ophtha.2024.09.012
Kanishk Singh, Sagarika Snehi, Rajesh Pattebahadur
{"title":"Amblyogenic Apex: The Pyramid Within the Eye.","authors":"Kanishk Singh, Sagarika Snehi, Rajesh Pattebahadur","doi":"10.1016/j.ophtha.2024.09.012","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.09.012","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Amniotic Membrane Grafting for the Treatment of Chemical and Thermal Ocular Surface Injuries: A Report by the American Academy of Ophthalmology. 羊膜移植治疗化学和热眼表损伤的疗效:美国眼科学会报告。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ophtha.2024.08.021
Peter B Veldman, Mark A Greiner, Maria S Cortina, Anthony N Kuo, Jennifer Y Li, Darby D Miller, Roni M Shtein, Mitchell P Weikert, Jia Yin, Stephen J Kim, Joanne F Shen

Objective: To evaluate the published literature on the efficacy of amniotic membrane grafting (AMG) in the management of acute chemical and thermal ocular surface burns with respect to the rate of corneal re-epithelialization and improvement of visual acuity or corneal clarity.

Methods: Literature searches were conducted in the PubMed database in May 2023 and updated in January 2024 and were limited to the English language without date restrictions. The searches yielded 474 citations; 58 were reviewed in full text, and 9 met the inclusion criteria. Four studies were rated level II, and 5 studies were rated level III. This assessment focuses on 3 level II articles that provided consistent primary and secondary outcomes but demonstrated suboptimal study design with respect to power calculations and lacked a priori sample-size calculations.

Results: Amniotic membrane grafting significantly improved corneal re-epithelialization compared with medical therapy alone in eyes with moderate-grade burns. For severely burned eyes, AMG demonstrated no advantage over medical therapy. Additionally, AMG demonstrated no significant advantage over medical therapy for improved visual acuity or corneal clarity for moderate or severe ocular surface burns.

Conclusions: The best available level II evidence suggests that AMG in the setting of acute ocular surface burns has efficacy in hastening re-epithelialization in moderate burns. As an adjuvant to medical therapy, it did not demonstrate a benefit in improving re-epithelialization in severe burns or visual acuity or corneal clarity in either moderate or severe burns.

Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.

目的评估已发表的有关羊膜移植术(AMG)治疗急性化学性和热性眼表烧伤在角膜再上皮化率和改善视力或角膜清晰度方面疗效的文献:于 2023 年 5 月在 PubMed 数据库中进行了文献检索,并于 2024 年 1 月进行了更新,检索仅限于英语,无日期限制。搜索共获得 474 篇引文,其中 58 篇进行了全文审阅,9 篇符合纳入标准。4 项研究被评为 II 级,5 项研究被评为 III 级。本次评估主要针对 3 篇二级文章,这些文章提供了一致的主要和次要结果,但在功率计算方面显示出研究设计不够理想,并且缺乏先验样本量计算:结果:与单纯药物治疗相比,羊膜移植能显著改善中度烧伤眼的角膜再上皮化。对于严重烧伤的眼睛,AMG 与药物治疗相比没有优势。此外,对于中度或重度眼表烧伤,AMG 在改善视力或角膜清晰度方面与药物疗法相比没有明显优势:现有的最佳二级证据表明,在急性眼表烧伤的情况下,AMG 对加速中度烧伤的再上皮化有一定疗效。作为药物治疗的辅助疗法,AMG 在改善重度烧伤的再上皮化、中度或重度烧伤的视力或角膜清晰度方面并未显示出其益处:专利或商业信息披露请参见参考文献。
{"title":"Efficacy of Amniotic Membrane Grafting for the Treatment of Chemical and Thermal Ocular Surface Injuries: A Report by the American Academy of Ophthalmology.","authors":"Peter B Veldman, Mark A Greiner, Maria S Cortina, Anthony N Kuo, Jennifer Y Li, Darby D Miller, Roni M Shtein, Mitchell P Weikert, Jia Yin, Stephen J Kim, Joanne F Shen","doi":"10.1016/j.ophtha.2024.08.021","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.021","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the published literature on the efficacy of amniotic membrane grafting (AMG) in the management of acute chemical and thermal ocular surface burns with respect to the rate of corneal re-epithelialization and improvement of visual acuity or corneal clarity.</p><p><strong>Methods: </strong>Literature searches were conducted in the PubMed database in May 2023 and updated in January 2024 and were limited to the English language without date restrictions. The searches yielded 474 citations; 58 were reviewed in full text, and 9 met the inclusion criteria. Four studies were rated level II, and 5 studies were rated level III. This assessment focuses on 3 level II articles that provided consistent primary and secondary outcomes but demonstrated suboptimal study design with respect to power calculations and lacked a priori sample-size calculations.</p><p><strong>Results: </strong>Amniotic membrane grafting significantly improved corneal re-epithelialization compared with medical therapy alone in eyes with moderate-grade burns. For severely burned eyes, AMG demonstrated no advantage over medical therapy. Additionally, AMG demonstrated no significant advantage over medical therapy for improved visual acuity or corneal clarity for moderate or severe ocular surface burns.</p><p><strong>Conclusions: </strong>The best available level II evidence suggests that AMG in the setting of acute ocular surface burns has efficacy in hastening re-epithelialization in moderate burns. As an adjuvant to medical therapy, it did not demonstrate a benefit in improving re-epithelialization in severe burns or visual acuity or corneal clarity in either moderate or severe burns.</p><p><strong>Financial disclosure(s): </strong>Proprietary or commercial disclosure may be found after the references.</p>","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular Cysticercosis: Live Worm in Anterior Chamber. 眼囊虫病:前房中的活虫
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ophtha.2024.08.015
Tanvi Soni, Pradeep Agarwal, Suraj Kumar Chaurasiya
{"title":"Ocular Cysticercosis: Live Worm in Anterior Chamber.","authors":"Tanvi Soni, Pradeep Agarwal, Suraj Kumar Chaurasiya","doi":"10.1016/j.ophtha.2024.08.015","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.015","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Illustrating the Visual Field Effects of a Migraine Aura. 说明偏头痛先兆对视野影响的病例。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ophtha.2024.08.010
James Morris, Jonathan Rossiter
{"title":"Case Illustrating the Visual Field Effects of a Migraine Aura.","authors":"James Morris, Jonathan Rossiter","doi":"10.1016/j.ophtha.2024.08.010","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.010","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cysticercus Cellulosae Masquerading as an Encapsulated Bleb. 伪装成囊泡的纤维囊尾蚴
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ophtha.2024.09.006
Arshi Singh, Kirti Singh, Aastha Singh
{"title":"Cysticercus Cellulosae Masquerading as an Encapsulated Bleb.","authors":"Arshi Singh, Kirti Singh, Aastha Singh","doi":"10.1016/j.ophtha.2024.09.006","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.09.006","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral Optic Disc Edema due to Traumatic Vitreopapillary Traction. 外伤性玻璃体乳头牵引导致的单侧视盘水肿
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ophtha.2024.09.005
Anupam K Garg, Amanda D Henderson, Jacob G Light
{"title":"Unilateral Optic Disc Edema due to Traumatic Vitreopapillary Traction.","authors":"Anupam K Garg, Amanda D Henderson, Jacob G Light","doi":"10.1016/j.ophtha.2024.09.005","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.09.005","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral Congenital Cytomegalovirus Retinitis Secondary to LCK Gene Mutation. 继发于 LCK 基因突变的双侧先天性巨细胞病毒视网膜炎。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-05 DOI: 10.1016/j.ophtha.2024.08.035
Arpitha Kalava, Bhavik Panchal
{"title":"Bilateral Congenital Cytomegalovirus Retinitis Secondary to LCK Gene Mutation.","authors":"Arpitha Kalava, Bhavik Panchal","doi":"10.1016/j.ophtha.2024.08.035","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.035","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Experience of Technology-based Eye Care Services: A Comprehensive Ophthalmology Telemedicine Initiative. 基于技术的眼科护理服务(TECS)的全国经验:综合眼科远程医疗计划。
IF 4.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-04 DOI: 10.1016/j.ophtha.2024.09.032
Lilla S Simon, Melanie L Davis, Danira Medunjanin, Lauren Fanning, Jennifer C Damonte, Kelly Hunt, April Y Maa

Purpose: Technology-based Eye Care Services (TECS) is a tele-ophthalmology program operating in the Veterans' Health Administration since 2015. This study explores characteristics of the national TECS population, evaluates implementation and sustainability of TECS, and analyzes possible associations and effects of demographic characteristics and social determinants of health on being diagnosed with a vision-threatening (VT) disease.

Design: Implementation and sustainability of TECS from 2015 to 2022 were examined along with the sociodemographic characteristics of veterans served through TECS in 2021.

Participants: Veteran patients seen in TECS nationwide.

Main outcome measures: Characteristics, disease prevalence and diagnoses, implementation success rate, sustainability rate, and preliminary analysis of outcomes and disparity.

Methods: Per quarter from 2015 to 2022, TECS sites were classified as implementing, active, or sustained. Standard query language was used to determine sociodemographic data, and logistic regression models were used to identify risk factors associated with VT eye diagnosis.

Results: A total of 21 712 Veterans, 52.1% rural or highly rural, were served by TECS in 2021. The average age was 64.7 years, with women comprising 10.9% of the population served. From 2015 to 2022, of the 67 TECS sites initiated, 6 were implementing with 51 of 61 initiated sites still operational in the first quarter (Q1) of 2022 (83.6% success rate). Age-related macular degeneration (AMD) and cataracts were more prevalent in rural and highly rural populations (7.6% and 11.3%, and 48.8% and 55.0%, respectively) versus urban populations (5.8% and 47.8%); glaucoma and diabetic retinopathy (DR) had the opposite association. The prevalence of any type of VT eye disease was lowest in the Mountains/Central region (0.54%) and highest in the Southeast region (3.2%) of the United States. Rural and highly rural residents were 1.3 and 2.5 times as likely, respectively, to be diagnosed with a VT eye disease than urban residents.

Conclusions: Implementation and sustainability of TECS have been promising. The data provide key information that can be used to improve the deployment of TECS and similar programs, along with the possible future direction of TECS. Moreover, experience from one national ocular telehealth program clearly illustrates that telemedicine can address eye care disparities in the Veteran population and may be used for other vulnerable groups as well.

Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.

目的:基于技术的眼科护理服务(TECS)是退伍军人管理局自 2015 年起开展的一项远程眼科项目。本研究探讨了全国 TECS 人口的特征,评估了 TECS 的实施情况和可持续性,并分析了人口特征和健康的社会决定因素(SDOH)对被诊断出患有视力威胁(VT)疾病可能产生的关联和影响:设计:研究了 2015-2022 年 TECS 的实施情况和可持续性,以及 2021 年通过 TECS 服务的退伍军人的社会人口特征:主要结果测量:主要结果测量:特征、疾病流行率和诊断、实施成功率、持续率、结果和差异的初步分析:从 2015 年到 2022 年的每个季度,TECS 站点被划分为实施、活跃或持续。使用标准查询语言(SQL)确定社会人口学数据,并使用逻辑回归模型确定与 VT 眼科诊断相关的风险因素。结果:2021 年,TECS 共为 21712 名退伍军人提供了服务,其中 52.1%为农村或高度农村退伍军人。平均年龄为 64.7 岁,女性占服务人口的 10.9%。与城市人口相比,黄斑变性(AMD)和白内障在农村和高度农村人口中的发病率更高(分别为 7.6% 和 11.3%,以及 48.8% 和 55.0%);青光眼和糖尿病视网膜病变(DR)的发病率则与之相反。任何一种 VT 眼病的患病率在美国山区/中部地区最低(0.54%),在东南部地区最高(3.2%)。与城市居民相比,农村居民和高度农村居民被诊断出患有 VT 眼病的几率分别是城市居民的 1.3 倍和 2.5 倍:结论:TECS 的实施和可持续发展前景良好。这些数据提供了关键信息,可用于改进 TECS 和类似项目的部署,以及 TECS 服务未来可能的发展方向。此外,一个全国性眼科远程保健项目的经验清楚地表明,远程医疗可以解决退伍军人群体中的眼科保健差异,也可用于其他弱势群体。
{"title":"National Experience of Technology-based Eye Care Services: A Comprehensive Ophthalmology Telemedicine Initiative.","authors":"Lilla S Simon, Melanie L Davis, Danira Medunjanin, Lauren Fanning, Jennifer C Damonte, Kelly Hunt, April Y Maa","doi":"10.1016/j.ophtha.2024.09.032","DOIUrl":"10.1016/j.ophtha.2024.09.032","url":null,"abstract":"<p><strong>Purpose: </strong>Technology-based Eye Care Services (TECS) is a tele-ophthalmology program operating in the Veterans' Health Administration since 2015. This study explores characteristics of the national TECS population, evaluates implementation and sustainability of TECS, and analyzes possible associations and effects of demographic characteristics and social determinants of health on being diagnosed with a vision-threatening (VT) disease.</p><p><strong>Design: </strong>Implementation and sustainability of TECS from 2015 to 2022 were examined along with the sociodemographic characteristics of veterans served through TECS in 2021.</p><p><strong>Participants: </strong>Veteran patients seen in TECS nationwide.</p><p><strong>Main outcome measures: </strong>Characteristics, disease prevalence and diagnoses, implementation success rate, sustainability rate, and preliminary analysis of outcomes and disparity.</p><p><strong>Methods: </strong>Per quarter from 2015 to 2022, TECS sites were classified as implementing, active, or sustained. Standard query language was used to determine sociodemographic data, and logistic regression models were used to identify risk factors associated with VT eye diagnosis.</p><p><strong>Results: </strong>A total of 21 712 Veterans, 52.1% rural or highly rural, were served by TECS in 2021. The average age was 64.7 years, with women comprising 10.9% of the population served. From 2015 to 2022, of the 67 TECS sites initiated, 6 were implementing with 51 of 61 initiated sites still operational in the first quarter (Q1) of 2022 (83.6% success rate). Age-related macular degeneration (AMD) and cataracts were more prevalent in rural and highly rural populations (7.6% and 11.3%, and 48.8% and 55.0%, respectively) versus urban populations (5.8% and 47.8%); glaucoma and diabetic retinopathy (DR) had the opposite association. The prevalence of any type of VT eye disease was lowest in the Mountains/Central region (0.54%) and highest in the Southeast region (3.2%) of the United States. Rural and highly rural residents were 1.3 and 2.5 times as likely, respectively, to be diagnosed with a VT eye disease than urban residents.</p><p><strong>Conclusions: </strong>Implementation and sustainability of TECS have been promising. The data provide key information that can be used to improve the deployment of TECS and similar programs, along with the possible future direction of TECS. Moreover, experience from one national ocular telehealth program clearly illustrates that telemedicine can address eye care disparities in the Veteran population and may be used for other vulnerable groups as well.</p><p><strong>Financial disclosure(s): </strong>Proprietary or commercial disclosure may be found after the references.</p>","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":4.1,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraoperative Aberrometry versus Preoperative Biometry for Intraocular Lens Power Calculations: A Report by the American Academy of Ophthalmology. 术中像差测量法与术前生物测量法在眼内透镜功率计算中的对比:美国眼科学会报告。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-03 DOI: 10.1016/j.ophtha.2024.08.007
Seth M Pantanelli, Kathryn Hatch, Charles C Lin, W Allan Steigleman, Zaina Al-Mohtaseb, Jennifer R Rose-Nussbaumer, Marcony R Santhiago, Tiarnán D L Keenan, Stephen J Kim, Deborah S Jacobs, Julie M Schallhorn

Purpose: To evaluate the published literature to compare intraoperative aberrometry (IA) with preoperative biometry-based formulas with respect to intraocular lens (IOL) power calculation accuracy for various clinical scenarios.

Methods: Literature searches in the PubMed database conducted in August 2022, July 2023, and February 2024 identified 157, 18, and 6 citations, respectively. These were reviewed in abstract form, and 61 articles were selected for full-text review. Of these, 29 met the criteria for inclusion in this assessment. The panel methodologists assigned a level of evidence rating to each of the articles; 4 were rated level I, 19 were rated level II, and 6 were rated level III.

Results: Intraoperative aberrometry performed better than traditional vergence formulas, including the Haigis, HofferQ, Holladay, and SRK/T, and similarly to the Barrett Universal II and Hill-RBF with respect to minimization of spherical equivalent (SE) refractive error. For toric IOLs, IA outperformed formulas that only considered anterior corneal astigmatism and was similar to formulas like the Barrett Toric Calculator (BTC), which empirically account for the contribution from the posterior cornea. In eyes with a history of corneal refractive surgery, IA performed similarly to the Barrett True-K and slightly better than other tested methods, including the Haigis-L, Shammas, and Wang-Koch-Maloney formulas.

Conclusions: Intraoperative aberrometry corresponds well with modern vergence formulas, including the Barrett Universal II, Hill-RBF, BTC, and Barrett True-K. It has greater accuracy than traditional vergence-based IOL power calculation formulas in eyes with and without a history of corneal refractive surgery.

Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.

目的:评估已发表的文献,比较术中像差法(IA)与基于术前生物测量的公式在各种临床情况下眼球内晶状体(IOL)功率计算的准确性:方法:分别于 2022 年 8 月、2023 年 7 月和 2024 年 2 月在 PubMed 数据库中进行了文献检索,发现了 157、18 和 6 篇引文。对这些文献进行了摘要审查,并选择了 61 篇文章进行全文审查。其中 29 篇符合纳入本评估的标准。小组方法论专家对每篇文章进行了证据等级评定:4 篇文章被评为 I 级,19 篇文章被评为 II 级,6 篇文章被评为 III 级:结果:术中像差测量法在最小化球面等效(SE)屈光不正方面的表现优于传统的辐辏公式,包括Haigis、HofferQ、Holladay和SRK/T,与Barrett Universal II和Hill-RBF相似。对于散光人工晶体,IA 的性能优于只考虑前角膜散光的公式,与巴雷特散光计算器(BTC)等公式相似,后者根据经验考虑了后角膜的贡献。在有角膜屈光手术史的眼睛中,IA的表现与Barrett True-K相似,略优于其他测试方法,包括Haigis-L、Shammas和Wang-Koch-Maloney公式:结论:术中像差测量法与现代辐辏公式(包括 Barrett Universal II、Hill-RBF、BTC 和 Barrett True-K)非常吻合。在有角膜屈光手术史和没有角膜屈光手术史的眼睛中,它比传统的基于辐辏的人工晶体功率计算公式更准确:专利或商业信息披露请参见参考文献。
{"title":"Intraoperative Aberrometry versus Preoperative Biometry for Intraocular Lens Power Calculations: A Report by the American Academy of Ophthalmology.","authors":"Seth M Pantanelli, Kathryn Hatch, Charles C Lin, W Allan Steigleman, Zaina Al-Mohtaseb, Jennifer R Rose-Nussbaumer, Marcony R Santhiago, Tiarnán D L Keenan, Stephen J Kim, Deborah S Jacobs, Julie M Schallhorn","doi":"10.1016/j.ophtha.2024.08.007","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.007","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the published literature to compare intraoperative aberrometry (IA) with preoperative biometry-based formulas with respect to intraocular lens (IOL) power calculation accuracy for various clinical scenarios.</p><p><strong>Methods: </strong>Literature searches in the PubMed database conducted in August 2022, July 2023, and February 2024 identified 157, 18, and 6 citations, respectively. These were reviewed in abstract form, and 61 articles were selected for full-text review. Of these, 29 met the criteria for inclusion in this assessment. The panel methodologists assigned a level of evidence rating to each of the articles; 4 were rated level I, 19 were rated level II, and 6 were rated level III.</p><p><strong>Results: </strong>Intraoperative aberrometry performed better than traditional vergence formulas, including the Haigis, HofferQ, Holladay, and SRK/T, and similarly to the Barrett Universal II and Hill-RBF with respect to minimization of spherical equivalent (SE) refractive error. For toric IOLs, IA outperformed formulas that only considered anterior corneal astigmatism and was similar to formulas like the Barrett Toric Calculator (BTC), which empirically account for the contribution from the posterior cornea. In eyes with a history of corneal refractive surgery, IA performed similarly to the Barrett True-K and slightly better than other tested methods, including the Haigis-L, Shammas, and Wang-Koch-Maloney formulas.</p><p><strong>Conclusions: </strong>Intraoperative aberrometry corresponds well with modern vergence formulas, including the Barrett Universal II, Hill-RBF, BTC, and Barrett True-K. It has greater accuracy than traditional vergence-based IOL power calculation formulas in eyes with and without a history of corneal refractive surgery.</p><p><strong>Financial disclosure(s): </strong>Proprietary or commercial disclosure may be found after the references.</p>","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retained Intraocular Cilium without Signs of Prior Ocular Injury or Surgery. 眼内纤毛残留,但无眼部损伤或手术迹象。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.ophtha.2024.08.032
Gladys Lee
{"title":"Retained Intraocular Cilium without Signs of Prior Ocular Injury or Surgery.","authors":"Gladys Lee","doi":"10.1016/j.ophtha.2024.08.032","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.032","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1